Leganto

Medicinal product

(Invented) name

Leganto

Active substance (s)

Rotigotinas

Strength

2 mg/24 h

Pharmaceutical form

transderminis pleistras

Route (s) of administration

vartoti per odą

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N04BC09, Rotigotine

Marketing authorisation holder

UCB Pharma S.A., Belgija

Date of authorisation

2011-06-16

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10c

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Transdermal patch	1 vnt.
Rotigotinas	2 mg/24 h

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
47440	61257	1061257	paketėlis	N7		Receptinis	EU/1/11/695/010	Netiekiama	-	-	No	-	-
47442	61259	1061259	paketėlis	N28		Receptinis	EU/1/11/695/012	Netiekiama	-	-	No	-	-
47443	61260	1061260	paketėlis	N30		Receptinis	EU/1/11/695/013	Netiekiama	-	-	No	-	-
47446	61263	1061263	paketėlis	N84 (sudėtinė 2x42)		Receptinis	EU/1/11/695/016	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-12-13	Išregistruotas
2011-06-16	Registruotas